- UK drug watchdogs have approved the use of semaglutide for preventing heart attacks and strokes.
- The decision was based on a trial that showed patients on the drug slashed their risk by up to a fifth.
- The medication will be offered to obese and overweight adults with cardiovascular disease.
- It’s the first weight loss drug to be prescribed for preventing cardiovascular events.
- The drug works by triggering the body to produce a hormone that makes people feel full, aiding in weight loss.
Source link
Cardiology, Diabetes & Endocrinology, Family Medicine, Public Health & Prevention